只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 16,508 | US$26.13 | US$431,354.04 | 19,044 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 50 | US$26.17 | US$1,308.50 | 18,994 | SEC |
| 2026-07-21 2026-07-23 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$80.59 | US$282,065.00 | 153,902 | SEC |
| 2026-07-13 2026-07-14 | LRCX LAM RESEARCH CORP | TALWALKAR ABHIJIT Y Director | 卖出（S） | 18,282 | US$335.00 | US$612.45万 | 87,142 | SEC |
| 2026-07-07 2026-07-07 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$86.62 | US$303,170.00 | 153,902 | SEC |
| 2026-07-02 2026-07-06 | LRCX LAM RESEARCH CORP | ARCHER TIMOTHY Officer · President and CEO | 卖出（S） | 30,000 | US$390.01 | US$1170.03万 | 1,075,966 | SEC |
| 2026-07-01 2026-07-02 | RPRX Royalty Pharma plc | Urist Marshall Officer · EVP, Research & Investments | 卖出（S） | 9,099 | US$55.88 | US$508,453.94 | 0 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 2,531 | US$1.93 | US$4,884.83 | 21,729 | SEC |
| 2026-06-25 2026-06-26 | IONS IONIS PHARMACEUTICALS INC | Swayze Eric Officer · EVP Research | 卖出（S） | 10,602 | US$79.18 | US$839,466.36 | 21,759 | SEC |
| 2026-06-24 2026-06-25 | RPRX Royalty Pharma plc | Urist Marshall Officer · EVP, Research & Investments | 卖出（S） | 9,098 | US$55.18 | US$502,027.64 | 9,099 | SEC |
| 2026-06-23 2026-06-23 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$79.51 | US$278,285.00 | 153,902 | SEC |
| 2026-06-15 2026-06-16 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 2,067 | US$2.22 | US$4,588.74 | 19,198 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 5,037 | US$370.27 | US$186.5万 | 162,238 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,600 | US$373.09 | US$596,944.00 | 144,705 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 4,030 | US$368.03 | US$148.32万 | 171,473 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 5,803 | US$367.01 | US$212.98万 | 175,503 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,200 | US$365.16 | US$438,192.00 | 181,306 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 2,300 | US$364.41 | US$838,143.00 | 182,506 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 2,345 | US$363.33 | US$852,008.85 | 184,806 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 2,708 | US$362.40 | US$981,379.20 | 187,151 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 819 | US$361.21 | US$295,830.99 | 189,859 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,906 | US$360.15 | US$686,445.90 | 190,678 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 3,828 | US$359.08 | US$137.46万 | 192,584 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,100 | US$357.98 | US$393,778.00 | 196,412 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,393 | US$357.24 | US$497,635.32 | 197,512 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 300 | US$355.71 | US$106,713.00 | 198,905 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 8,233 | US$371.17 | US$305.58万 | 154,005 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 7,700 | US$372.23 | US$286.62万 | 146,305 | SEC |
| 2026-06-12 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 4,198 | US$369.16 | US$154.97万 | 167,275 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 2,832 | US$345.84 | US$979,418.88 | 236,241 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 974 | US$337.56 | US$328,783.44 | 252,731 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,083 | US$338.62 | US$366,725.46 | 251,648 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,895 | US$339.75 | US$643,826.25 | 249,753 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,277 | US$340.68 | US$435,048.36 | 248,476 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,070 | US$341.81 | US$365,736.70 | 247,406 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 3,644 | US$342.91 | US$124.96万 | 243,762 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,481 | US$343.96 | US$509,404.76 | 242,281 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 3,208 | US$344.92 | US$110.65万 | 239,073 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 642 | US$364.00 | US$233,688.00 | 199,205 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 3,442 | US$346.79 | US$119.37万 | 232,799 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 6,592 | US$347.86 | US$229.31万 | 226,207 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 4,334 | US$348.73 | US$151.14万 | 221,873 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,517 | US$349.79 | US$530,631.43 | 220,356 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 36 | US$350.77 | US$12,627.72 | 220,320 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,172 | US$353.52 | US$414,325.44 | 219,148 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,461 | US$354.08 | US$517,310.88 | 217,687 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,331 | US$355.50 | US$473,170.50 | 216,356 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,653 | US$356.27 | US$588,914.31 | 214,703 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,455 | US$357.06 | US$519,522.30 | 213,248 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,880 | US$358.22 | US$673,453.60 | 211,368 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 780 | US$359.24 | US$280,207.20 | 210,588 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 664 | US$360.24 | US$239,199.36 | 209,924 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 1,756 | US$361.05 | US$634,003.80 | 208,168 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 2,604 | US$362.20 | US$943,168.80 | 205,564 | SEC |
| 2026-06-11 2026-06-15 | LRCX LAM RESEARCH CORP | BRANDT ERIC Director | 卖出（S） | 5,717 | US$362.95 | US$207.5万 | 199,847 | SEC |
| 2026-06-11 2026-06-12 | ESEA EUROSEAS LTD. | Pittas Aristeidis P Director | 买入（P） | 250 | US$67.18 | US$16,795.00 | 58,050 | SEC |
| 2026-06-11 2026-06-12 | ESEA EUROSEAS LTD. | Pittas Aristeidis P Director | 买入（P） | 250 | US$67.18 | US$16,795.00 | 58,050 | SEC |
| 2026-06-09 2026-06-09 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$67.98 | US$237,930.00 | 153,902 | SEC |
| 2026-06-05 2026-06-05 | ACMR ACM Research, Inc. | Cheav Sotheara Officer · See remarks | 卖出（S） | 400 | US$84.01 | US$33,604.00 | 101,649 | SEC |
| 2026-06-05 2026-06-05 | ACMR ACM Research, Inc. | Cheav Sotheara Officer · See remarks | 卖出（S） | 2,384 | US$81.73 | US$194,844.32 | 103,017 | SEC |
| 2026-06-05 2026-06-05 | ACMR ACM Research, Inc. | Cheav Sotheara Officer · See remarks | 卖出（S） | 968 | US$82.61 | US$79,966.48 | 102,049 | SEC |
| 2026-06-05 2026-06-05 | ACMR ACM Research, Inc. | Cheav Sotheara Officer · See remarks | 卖出（S） | 1,647 | US$85.41 | US$140,670.27 | 100,002 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 10,992 | US$86.07 | US$946,081.44 | 812,115 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 17,543 | US$85.11 | US$149.31万 | 823,107 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 2,060 | US$83.86 | US$172,751.60 | 840,650 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 8,581 | US$87.13 | US$747,662.53 | 803,534 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 826 | US$87.91 | US$72,613.66 | 802,708 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Cheav Sotheara Officer · See remarks | 卖出（S） | 2,839 | US$85.77 | US$243,501.03 | 100,002 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Cheav Sotheara Officer · See remarks | 卖出（S） | 1,300 | US$84.08 | US$109,304.00 | 112,053 | SEC |
| 2026-06-04 2026-06-05 | ACMR ACM Research, Inc. | Cheav Sotheara Officer · See remarks | 卖出（S） | 9,212 | US$85.11 | US$784,033.32 | 102,841 | SEC |
| 2026-06-03 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 1,187 | US$93.04 | US$110,438.48 | 802,708 | SEC |
| 2026-06-03 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 4,300 | US$87.57 | US$376,551.00 | 858,408 | SEC |
| 2026-06-03 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 6,295 | US$88.98 | US$560,129.10 | 852,113 | SEC |
| 2026-06-03 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 32,450 | US$89.84 | US$291.53万 | 819,663 | SEC |
| 2026-06-03 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 9,925 | US$90.78 | US$900,991.50 | 809,738 | SEC |
| 2026-06-03 2026-06-05 | ACMR ACM Research, Inc. | Wang David H Director,Officer,TenPercentOwner · See Remarks | 卖出（S） | 5,843 | US$92.38 | US$539,776.34 | 803,895 | SEC |
| 2026-06-01 2026-06-02 | LRCX LAM RESEARCH CORP | Fernandes Neil J Officer · Senior Vice President | 卖出（S） | 7,659 | US$309.60 | US$237.12万 | 58,470 | SEC |
| 2026-05-29 2026-06-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,786 | US$2.57 | US$4,590.02 | 17,131 | SEC |
| 2026-05-26 2026-05-28 | EXEL EXELIXIS, INC. | Aftab Dana Officer · EVP, Research and Development | 卖出（S） | 43,451 | US$50.35 | US$218.78万 | 594,741 | SEC |
| 2026-05-21 2026-05-22 | ACLS AXCELIS TECHNOLOGIES INC | Blumenstock Gerald M Officer · EVP, Research, Dev. & Eng. | 卖出（S） | 1,161 | US$152.70 | US$177,284.70 | 20,493 | SEC |
| 2026-05-20 2026-05-21 | RPRX Royalty Pharma plc | Urist Marshall Officer · EVP, Research & Investments | 卖出（S） | 13,684 | US$52.75 | US$721,831.00 | 18,197 | SEC |
| 2026-05-19 2026-05-21 | ACMR ACM Research, Inc. | Dun Haiping Director | 卖出（S） | 500 | US$65.09 | US$32,545.00 | 3,167 | SEC |
| 2026-05-19 2026-05-21 | ACMR ACM Research, Inc. | Dun Haiping Director | 卖出（S） | 1,333 | US$63.84 | US$85,098.72 | 3,667 | SEC |
| 2026-05-19 2026-05-21 | ACMR ACM Research, Inc. | Dun Haiping Director | 卖出（S） | 1,858 | US$67.54 | US$125,489.32 | 0 | SEC |
| 2026-05-19 2026-05-21 | ACMR ACM Research, Inc. | Dun Haiping Director | 卖出（S） | 1,309 | US$67.21 | US$87,977.89 | 1,858 | SEC |
| 2026-05-19 2026-05-20 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$75.69 | US$264,915.00 | 153,902 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Raymon Heather Officer · SVP, Research and Development | 卖出（S） | 3,095 | US$9.01 | US$27,885.95 | 148,228 | SEC |
| 2026-05-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,545 | US$2.97 | US$4,588.65 | 15,345 | SEC |
| 2026-05-14 2026-05-15 | RPRX Royalty Pharma plc | Urist Marshall Officer · EVP, Research & Investments | 卖出（S） | 13,684 | US$53.06 | US$726,073.04 | 31,881 | SEC |
| 2026-05-14 2026-05-15 | ACLS AXCELIS TECHNOLOGIES INC | Blumenstock Gerald M Officer · EVP, Research, Dev. & Eng. | 卖出（S） | 1,015 | US$162.32 | US$164,754.80 | 17,293 | SEC |
| 2026-05-06 2026-05-06 | TVTX Travere Therapeutics, Inc. | ROTE WILLIAM E. Officer · Chief Research Officer | 卖出（S） | 2,763 | US$43.95 | US$121,433.85 | 115,474 | SEC |
| 2026-05-05 2026-05-05 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$77.37 | US$270,795.00 | 153,902 | SEC |
| 2026-05-04 2026-05-05 | SRZN Surrozen, Inc./DE | Li Yang Officer · Exec. Vice President, Research | 卖出（S） | 1,584 | US$33.33 | US$52,794.72 | 17,216 | SEC |
| 2026-05-04 2026-05-04 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan Officer · President, Research & Develop. | 卖出（S） | 25,907 | US$15.39 | US$398,708.73 | 216,317 | SEC |
| 2026-05-01 2026-05-04 | LRCX LAM RESEARCH CORP | Fernandes Neil J Officer · Senior Vice President | 卖出（S） | 18,170 | US$255.14 | US$463.59万 | 66,129 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,706 | US$2.69 | US$4,589.14 | 13,813 | SEC |
| 2026-04-27 2026-04-28 | LRCX LAM RESEARCH CORP | Harter Ava Officer · Chief Legal Officer | 卖出（S） | 6,010 | US$258.66 | US$155.45万 | 53,205.46 | SEC |
| 2026-04-22 2026-04-23 | TVTX Travere Therapeutics, Inc. | ROTE WILLIAM E. Officer · Chief Research Officer | 卖出（S） | 9,100 | US$39.09 | US$355,719.00 | 113,987 | SEC |
| 2026-04-22 2026-04-23 | SGMO SANGAMO THERAPEUTICS, INC | Davis Gregory D Officer · Head of Research & Technology | 卖出（S） | 69,827 | US$0.25 | US$17,456.75 | 115,284 | SEC |
| 2026-04-21 2026-04-21 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$65.69 | US$229,915.00 | 153,902 | SEC |
| 2026-04-17 2026-04-21 | ACMR ACM Research, Inc. | Pappis Charles C Director | 卖出（S） | 5,000 | US$52.00 | US$260,000.00 | 0 | SEC |
| 2026-04-16 2026-04-20 | ESEA EUROSEAS LTD. | Karmiri Stefania Officer · Corporate Secretary | 卖出（S） | 250 | US$72.00 | US$18,000.00 | 0 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,545 | US$2.97 | US$4,588.65 | 12,107 | SEC |
| 2026-04-14 2026-04-16 | ESEA EUROSEAS LTD. | Aslidis Anastasios Director,Officer · Chief Financial Officer | 买入（P） | 1,000 | US$70.82 | US$70,820.00 | 25,910 | SEC |
| 2026-04-14 2026-04-15 | ESEA EUROSEAS LTD. | Pittas Aristeidis P Director,Officer · Vice Chairman | 卖出（S） | 250 | US$70.20 | US$17,550.00 | 57,800 | SEC |
| 2026-04-14 2026-04-15 | ESEA EUROSEAS LTD. | Pittas Aristeidis P Director,Officer · Vice Chairman | 卖出（S） | 250 | US$70.20 | US$17,550.00 | 57,800 | SEC |
| 2026-04-07 2026-04-08 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 1,000 | US$64.75 | US$64,750.00 | 153,902 | SEC |
| 2026-04-07 2026-04-08 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$65.21 | US$228,235.00 | 153,902 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | Young David Director,Officer · Pres. Research & Development | 买入（P） | 1,810 | US$2.54 | US$4,597.40 | 10,562 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ESEA | 6,715.3548 | 0 | 16,170.9059 | 41.53% | B, Q, N |